2000ACP Journal ClubRequires access

Tissue plasminogen activator improved function at 6 and 12 months after ischemic stroke

Philip M. Bath

Open publisher page 0 citations

Abstract

Source Citation Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-7. 10362821

About this research paper

What this paper is about

Source Citation Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-7. 10362821

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Source Citation Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med. 1999;340:1781-7. 10362821

Key concepts: Medicine, Recombinant tissue plasminogen activator, Tissue plasminogen activator, Stroke (engine), Ischemic stroke, Plasminogen activator, Internal medicine, Ischemia

Related papers

Back to paper searchBrowse research topicsOriginal source
Tissue plasminogen activator improved function at 6 and 12 months after ischemic stroke — Research Paper | ScholarLens